Materials & Resources » Chemicals | Marrone Bio Innovations Inc.

Marrone Bio Innovations Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
14,543.00
9,136.00
9,801.00
14,042.00
18,167.00
21,220
Cost of Goods Sold (COGS) incl. D&A
10,736.00
9,438.00
9,256.00
9,522.00
10,528.00
10,907
Gross Income
3,807.00
302.00
545.00
4,520.00
7,639.00
10,313
SG&A Expense
32,832.00
48,231.00
40,002.00
26,430.00
30,265.00
29,817
EBIT
29,025.00
48,533.00
-
21,910.00
22,626.00
19,504
Unusual Expense
6,766.00
-
-
1,816.00
96.00
1,810
Non Operating Income/Expense
282.00
278.00
41.00
80.00
475.00
11
Interest Expense
5,997.00
2,907.00
4,363.00
7,302.00
7,729.00
2,508
Pretax Income
28,489.00
51,659.00
43,728.00
31,071.00
30,925.00
20,213
Consolidated Net Income
28,489.00
51,659.00
43,728.00
31,071.00
30,925.00
20,213
Net Income
28,489.00
51,659.00
43,728.00
31,071.00
30,925.00
20,213
Net Income After Extraordinaries
28,489.00
51,659.00
43,728.00
31,071.00
30,925.00
20,213
Net Income Available to Common
29,867.00
51,659.00
43,728.00
31,071.00
30,925.00
20,213
EPS (Basic)
3.94
2.32
1.79
1.26
1.06
0.20
Basic Shares Outstanding
8,731.00
22,314.00
24,469.00
24,617.00
29,235.00
101,248
EPS (Diluted)
3.94
2.32
1.79
1.26
1.06
0.20
Diluted Shares Outstanding
8,911.00
22,314.00
24,469.00
24,617.00
29,235.00
101,248
EBITDA
28,049.00
45,952.00
35,947.00
19,675.00
20,582.00
17,614
Non-Operating Interest Income
49.00
59.00
51.00
37.00
1.00
-
Preferred Dividends
1,378.00
-
-
-
-
-

About Marrone Bio Innovations

View Profile
Address
1540 Drew Avenue
Davis California 95618
United States
Employees -
Website http://www.marronebioinnovations.com
Updated 07/08/2019
Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate, and majestene. The company was founded by Pamela G.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.